Hall 4 (Salle C, Floor 0)

08:00 - 09:00 BUSINESS MEETING
09:00 - 10:30

Paediatric Cardiovascular Intensive Care

Chair: Damian Hutter, Switzerland
Co-chair: Nikolaus Haas, Germany

O-079 A bicentric propensity matched analysis of 158 patients comparing porcine versus bovine stented bioprosthetic valves in pulmonary position,
Bunty Ramchandani, Spain
O-080 Surgical Repair of Obstructed Total Anomalous Pulmonary Venous Connection in Infants: Results and Risk Factors for Mortality in a Single Centre Cohort,
Avishek Samaddar, United Kingdom
O-081 Aortic Root Dilatation after Ross Operation,
Nerejda Shehu, Germany
O-082 Effect of Platelet Transfusions on Extracorporeal Life Support Oxygenators' Function,
Oliver Karam, United States
O-083 Renal and Cardiac Effects of Remote Ischemic Preconditioning in Children Undergoing Cardiopulmonary Bypass Surgery,
Yuk Law, United States
O-084 Necrotizing enterocolitis and congenital heart disease,
Claire Bertail Galoin, France

10:30 - 11:00 BREAK
11:00 - 12:30

Cardiac Imaging / functional assessment & Interventional cardiology

Chair: Oliver Kretschmar, Switzerland
Co-chair: Emanuela Valsangiacomo, Switzerland

P-082 Neonatal cardiac, feed-and-wrap, free-breathing 4D Flow MRI is comparable to standard free-breathing 2D Flow assessment, Hannah Panayiotou, UK
P-063 The role of cardiac magnetic resonance imaging in pediatric myocarditis, Alper Guzeltas, Turkey
P-057 Reduced neonatal fronto-limbic connectivity is associated with higher externalizing symptoms in toddlers with Congenital Heart Disease, Alexandra Bonthrone, UK
P-085 Validation of various approaches to aorta, pulmonary artery and pulmonary branches measurements in CT scans, Jarosław Meyer Szary, Poland
P-119 Myocardial strain response to a preload challenge in the Fontan circulation, Simone Goa Diab, Norway
P-192 Piccolo in Interventional PDA Closure; Multicenter Study from Premature to Adolescent, Osman Baspinar, Turkey
P-322 First in Man Use of a Novel FDA Approved Stent Design for Congenital Heart Disease- the G-ARMOR Stent, Gareth Morgan, United States
P-181 How is the Melody™ TPV doing 15 years after implantation ?, Marc Gewillig, Belgium
P-200 Importance of RVOT gradient in the diagnosis of transcatheter pulmonary valve endocarditis, Salaets Thomas, Belgium
P-292 Institutional experience with the Occlutech© atrial flow regulator (AFR) in children with congenital heart disease, Adam Koleśnik, Poland
P-297 Implantation of a new transcatheter heart valve for pulmonary position: Meril's Myval™, Alper Guzeltas, Turkey
P-294 Does pulmonary artery stenting in single ventricle patients affect lung growth and function?, Alessia Callegari, Switzerland